Preparation of heparin and its use in the first clinical cases.

نویسنده

  • C H BEST
چکیده

M ANY OF UJ8, who were friends of the late Dr. Jay McLean, had looked forward with great pleasure to seeing him again at this tiune and to discussing the problems wlhich occupied so much of his attention. We all join Dr.. Wright in paying tribute to Dr. MlcLean, the discoverer of heparin, and to Professor W. H. Howell and his colleagues, who extended this work and focused our attention oIn many of the most important problenis in this field. A number of years ago Dr. McLean wrote to me and asked if we would take the responsibility for his collection of notes and reprints and other documents relating, to heparinr. I was honoured and extremely 1leased to accept this invitation. It is almost always true that a very careful search of the literature will reveal papers which anticipate, to varying degrees, the discovery of a signal advance ill medical or other sciences. In 1912, Doyon' published a paper in which he describes anl attempt to isolate and characterize ail anticoagulant released by the injection of peptone in a dog. This work was interrupted by World War I. There are a number of other intriguing findings in the literature, for example that of Schmidt2 in 1892, but their significance could only be appreciated after the discovery of heparin by Dr. McLean13 ill 1916. Onl November 14, 1940, Dr. Jay MeLean wrote me a long, letter describing the whole history of his work on heparin, and a great deal about his subsequent researches. I will quote parts of this letter.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preparation, properties and preclinical pharmacokinetics of low molecular weight heparin-modified isoliquiritigenin-loaded solid lipid nanoparticle

Low molecular weight heparin-modified isoliquiritigenin-loaded solid lipid nanoparticle (LMWH-ISL-SLN) was developed for injective application. The morphological observation, particle diameter and zeta potential of LMWH-ISL-SLN were characterized using transmission electron microscopy (TEM) and a Malvern Zetasizer. Its entrapment efficiency (EE) and drug loading (DL) were determined by ultracen...

متن کامل

Preparation, properties and preclinical pharmacokinetics of low molecular weight heparin-modified isoliquiritigenin-loaded solid lipid nanoparticle

Low molecular weight heparin-modified isoliquiritigenin-loaded solid lipid nanoparticle (LMWH-ISL-SLN) was developed for injective application. The morphological observation, particle diameter and zeta potential of LMWH-ISL-SLN were characterized using transmission electron microscopy (TEM) and a Malvern Zetasizer. Its entrapment efficiency (EE) and drug loading (DL) were determined by ultracen...

متن کامل

Comparison between complications of vascular surgery procedures with and without aPPT assessment and protamine sulfate reversal

 Abstract Background: Thrombosis will occur due to contact of blood with unepithelialized surfaces after vascular clamping and also blood stasis during vascular surgery. Heparin is administered to prevent thrombosis. The aPTT test is used for assurance of the anticoagulative effect of heparin. At the end of the operation heparin is neutralized by protamine sulfate in some centers. In this study...

متن کامل

Low Molecular Weight Heparin Overdose: A 10 Year Case Series

  Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults.  In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...

متن کامل

Hemorrhagic events in patients receiving heparin or enoxaparin in combination with Oral antithrombotics, NSAIDs, and antiplatelet medications: A multi-center case-series study

Background: Hemorrhagic events are amongst the major adverse effects of injectable anticoagulants such as heparin and enoxaparin. This necessitates close monitoring of their use for clinically relevant drug-drug interactions. Aim: To study the rate of hemorrhagic events, the anatomical site, and the severity of the hemorrhage in patients receiving heparin or enoxaparin in combination with clop...

متن کامل

Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial

Objective: Heparin and enoxaparin possess anti-inflammatory properties. We compared the effects of these drugs on inflammatory biomarkers in patients with ST-segment Elevated Myocardial Infarction (STEMI). Method: Thirty four patients with STEMI randomly separated in two groups and received standard doses of heparin and enoxaparin. The serum concentration of Serum Amyloid A (SAA), C-Reactive Pr...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation

دوره 19 1  شماره 

صفحات  -

تاریخ انتشار 1959